Skip to Main Content

Browse issues

Open Forum Infectious Diseases Cover Image for Volume 6, Issue 2
Volume 6, Issue 2
February 2019
EISSN 2328-8957

Volume 6, Issue 2, February 2019

Brief Report

Yasuaki Tagashira and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz016, https://doi.org/10.1093/ofid/ofz016
Matthew A Donahue and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz005, https://doi.org/10.1093/ofid/ofz005
Sadia Hussain and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz031, https://doi.org/10.1093/ofid/ofz031
Carmen De Mendoza and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz036, https://doi.org/10.1093/ofid/ofz036
Tony Antoniou and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz009, https://doi.org/10.1093/ofid/ofz009
Chloe Bryson-Cahn and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz028, https://doi.org/10.1093/ofid/ofz028
Georgina Meza-Radilla and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz008, https://doi.org/10.1093/ofid/ofz008

Major Article

Sophia Jung and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz018, https://doi.org/10.1093/ofid/ofz018
Fernando Lidón and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz041, https://doi.org/10.1093/ofid/ofz041
Jonathan Soverow and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz012, https://doi.org/10.1093/ofid/ofz012

In this study, we describe the evolution of electrocardiogram (ECG) changes in a contemporary United States-based cohort of treated patients, and we suggest that patients who already have prognostically important baseline ECG abnormalities will have continued progression of their conduction system disease despite antitrypanosomal pharmacotherapy.

Cassandra Oliver and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz023, https://doi.org/10.1093/ofid/ofz023
Kathleen A Linder and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz037, https://doi.org/10.1093/ofid/ofz037
Katia Giguère and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz010, https://doi.org/10.1093/ofid/ofz010
Sean Matthews and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz007, https://doi.org/10.1093/ofid/ofz007
Moon Kim and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz014, https://doi.org/10.1093/ofid/ofz014
Yi-Tsung Lin and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofy336, https://doi.org/10.1093/ofid/ofy336
Dheeraj Goyal and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofy357, https://doi.org/10.1093/ofid/ofy357
Marie E Killerby and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz017, https://doi.org/10.1093/ofid/ofz017
Bradley T Endres and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz013, https://doi.org/10.1093/ofid/ofz013
Wen Kai Chen and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz006, https://doi.org/10.1093/ofid/ofz006
Priya Bhagwat and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz022, https://doi.org/10.1093/ofid/ofz022
Jacqueline M McBride and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz003, https://doi.org/10.1093/ofid/ofz003
Ki Wook Kim and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz025, https://doi.org/10.1093/ofid/ofz025
Kira L Newman and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz011, https://doi.org/10.1093/ofid/ofz011
Oskar Olsson and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz015, https://doi.org/10.1093/ofid/ofz015

Editor's Choice

Joung Ha Park and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz002, https://doi.org/10.1093/ofid/ofz002
Marge Kartau and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz024, https://doi.org/10.1093/ofid/ofz024

This is an observational study of PML cases during 2004-2016 where each case was identified and verified by clinical data by several specialties and biomarkers. Better safety protocols are recommended for all PML related medications.

Correspondence

Jasmine R Marcelin and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz042, https://doi.org/10.1093/ofid/ofz042
Amedeo F Capetti and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz044, https://doi.org/10.1093/ofid/ofz044
Julian P Kaboggoza and others
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz035, https://doi.org/10.1093/ofid/ofz035

Podcast Transcript

Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofz054, https://doi.org/10.1093/ofid/ofz054

Review Article

Pranavi Sreeramoju
Open Forum Infectious Diseases, Volume 6, Issue 2, February 2019, ofy348, https://doi.org/10.1093/ofid/ofy348
Close
This Feature Is Available To Subscribers Only

Sign In or Create an Account

Close

This PDF is available to Subscribers Only

View Article Abstract & Purchase Options

For full access to this pdf, sign in to an existing account, or purchase an annual subscription.

Close